Japanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Kissei Pharmaceutical

Market Cap: JP¥159.8b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Shionogi

Market Cap: JP¥2.5t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Takeda Pharmaceutical

Market Cap: JP¥8.6t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.

Sumitomo Pharma

Market Cap: JP¥569.9b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Astellas Pharma

Market Cap: JP¥3.9t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Santen Pharmaceutical

Market Cap: JP¥601.2b

Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Tsumura

Market Cap: JP¥282.5b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥35.6b

Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.

Zeria Pharmaceutical

Market Cap: JP¥91.2b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Otsuka Holdings

Market Cap: JP¥6.0t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

PhoenixBio

Market Cap: JP¥1.4b

Provides contract testing services for medical product development in Japan, the United States, and internationally.

Kidswell Bio

Market Cap: JP¥7.2b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

Chugai Pharmaceutical

Market Cap: JP¥11.0t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

GNI Group

Market Cap: JP¥163.7b

Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.

PeptiDream

Market Cap: JP¥119.9b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Immuno-Biological Laboratories

Market Cap: JP¥8.7b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

WDB coco

Market Cap: JP¥6.3b

Provides contract and human resource services to pharmaceutical companies in Japan.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥60.5b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Astena Holdings

Market Cap: JP¥20.4b

Manufactures and sells medicine-related products in Japan.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥18.3b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥52.0b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥4.7t

Manufactures and sells pharmaceutical products in Japan and internationally.

Nippon Shinyaku

Market Cap: JP¥230.7b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Healios K.K

Market Cap: JP¥31.7b

Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

Fuji Pharma

Market Cap: JP¥48.2b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.